<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8709538</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5861</journal-id>
<journal-id journal-id-type="nlm-ta">Neurotoxicol Teratol</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurotoxicol Teratol</journal-id>
<journal-title-group>
<journal-title>Neurotoxicology and teratology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0892-0362</issn>
<issn pub-type="epub">1872-9738</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27327781</article-id>
<article-id pub-id-type="pmc">5897907</article-id>
<article-id pub-id-type="doi">10.1016/j.ntt.2016.06.006</article-id>
<article-id pub-id-type="manuscript">NIHMS803894</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Endocannabinoid System in the Baboon (<italic>Papio SPP</italic>.) as a Complex Framework for Developmental Pharmacology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rodriguez-Sanchez</surname>
<given-names>Iram P.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guindon</surname>
<given-names>Josee</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ruiz</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tejero</surname>
<given-names>Maria E.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hubbard</surname>
<given-names>Gene</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martinez-De-Villarreal</surname>
<given-names>Laura E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barrera-Saldaña</surname>
<given-names>Hugo A.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dick</surname>
<given-names>Edward J.</given-names>
<suffix>Jr.</suffix>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Commuzzie</surname>
<given-names>Anthony G</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schlabritz-Loutsevitch</surname>
<given-names>Natalia E</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Universidad Autónoma de Nuevo León, Facultad de Medicina, Departamento de Genética. Monterrey, Nuevo León, México</aff>
<aff id="A2">
<label>2</label>Department of Pharmacology and Neurobiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA</aff>
<aff id="A3">
<label>3</label>Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center at the Permian Basin, Odessa, TX, USA</aff>
<aff id="A4">
<label>4</label>Laboratorio de Nutrigenética y Nutrigenómica, Instituto Nacional de Medicina Genómica (INMEGEN), México, D.F., México</aff>
<aff id="A5">
<label>5</label>Department of Pathology, University of Texas at San Antonio, San Antonio, TX, USA</aff>
<aff id="A6">
<label>6</label>Universidad Autónoma de Nuevo León, Facultad de Medicina, Departamento de Bioquímica y Medicina Molecular. Monterrey, Nuevo León, México</aff>
<aff id="A7">
<label>7</label>Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA</aff>
<aff id="A8">
<label>8</label>Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding author: Natalia Schlabritz-Lutsevich MD, PhD, Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center School of Medicine at the Permian Basin, <email>Natalia.schlabritz-lutsevich@ttuhsc.edu</email>, Office phone: 432-703-5169, Cell phone: 210-317-0156</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<season>Nov-Dec</season>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>13</day>
<month>4</month>
<year>2018</year>
</pub-date>
<volume>58</volume>
<fpage>23</fpage>
<lpage>30</lpage>
<!--elocation-id from pubmed: 10.1016/j.ntt.2016.06.006-->
<abstract>
<sec id="S1">
<title>Introduction</title>
<p id="P1">The consumption of marijuana (exogenous cannabinoid) almost doubled in adults during last decade. Consumption of exogenous cannabinoids interferes with the endogenous cannabinoid (or “endocannabinoid” (eCB)) system (ECS), which comprises <italic>N</italic>-arachidonylethanolamide (anandamide, AEA), 2-arachidonoyl glycerol (2-AG), endocannabinoid receptors (cannabinoid receptors 1 and 2 (CB1R and CB2R), encoded by <italic>CNR1</italic> and <italic>CNR2</italic>, respectively), and synthesizing/degrading enzymes (FAAH, fatty-acid amide hydrolase; MAGL, monoacylglycerol lipase; DAGL-α, diacylglycerol lipase-alpha). Reports regarding the toxic and therapeutic effects of pharmacological compounds targeting the ECS are sometimes contradictory. This may be caused by the fact that structure of the eCBs varies in the species studied.</p>
</sec>
<sec id="S2">
<title>Objectives</title>
<p id="P2">First: to clone and characterize the cDNAs of selected members of ECS in a non-human primate (baboon, <italic>Papio</italic> spp.), and second: to compare those cDNA sequences to known human structural variants (single nucleotide polymorphisms and haplotypes).</p>
</sec>
<sec id="S3">
<title>Materials and methods</title>
<p id="P3">Polymerase chain reaction-amplified gene products from baboon tissues were transformed into <italic>Escherichia coli</italic>. Amplicon-positive clones were sequenced, and the obtained sequences were conceptually translated into amino-acid sequences using the genetic code.</p>
</sec>
<sec id="S4">
<title>Results</title>
<p id="P4">Among the ECS members, <italic>CNR1</italic> was the best conserved gene between humans and baboons. The phenotypes associated with mutations in the untranslated regions of this gene in humans have not been described in baboons. One difference in the structure of <italic>CNR2</italic> between humans and baboons was detected in the region with the only known clinically relevant polymorphism in a human receptor. All of the differences in the amino-acid structure of DAGL-α between humans and baboons were located in the hydroxylase domain, close to phosphorylation sites. None of the differences in the amino-acid structure of MAGL observed between baboons and humans were located in the area critical for enzyme function.</p>
</sec>
<sec id="S5">
<title>Conclusion</title>
<p id="P5">The evaluation of the data, obtained in non-human primate model of cannabis-related developmental exposure should take into consideration possible evolutionary-determined species-specific differences in the CB1R expression, CB2R transduction pathway, and FAAH and DAGLα substrate-enzyme interactions.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Non-human primates</kwd>
<kwd>development</kwd>
<kwd>endocannabinoid system</kwd>
<kwd>homology</kwd>
<kwd>pharmacology</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>